— Know what they know.
Not Investment Advice

RTSL OTC

Rapid Therapeutic Science Laboratories, Inc.
1W: +0.0% 1M: +0.0% 3M: +300.0% YTD: -80.0% 1Y: -86.7% 3Y: -99.9% 5Y: -99.9%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Neutral · Power 52 · $3533 mcap · 4M float · 0.0010% daily turnover · Short 70% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.000099999997-0.007
Volume9,500
Avg Volume36
Beta-1.83
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEODonal R. Schmidt Jr.
Employees3
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date2017-06-14
Websitertslco.com
558 County Road 472
De Leon, TX 76444
US
800 497 6059
About Rapid Therapeutic Science Laboratories, Inc.

Rapid Therapeutic Science Laboratories, Inc. (RTSL) is a biotechnology firm specializing in the aerosolized delivery of non-psychoactive cannabinoids directly into the bloodstream. This innovative approach is aimed at treating various conditions, including chronic pain, post-traumatic stress disorder (PTSD), insomnia, and aiding in surgery recovery, among other health issues. RTSL's product portfolio features pressurized meter dose inhalers (MDIs), designed to precisely dispense an aerosolized mist into the lungs, alongside sublingual oral spray devices. Furthermore, the company offers water-soluble cannabidiol (CBD) and cannabigerol (CBG) isolates under its "nhaler" brand. Established in 2013 and based in Dallas, Texas, the company adopted its current name, Rapid Therapeutic Science Laboratories, Inc., in January 2020, having previously operated as Holly Brothers Pictures, Inc. It was also formerly a subsidiary of Texas Mdi, Inc.

Latest News
No recent news

Recent Insider Trades

NameTypeSharesPriceDate
Berrier Sean Paul G-Gift 2,000,000 $0.26 2021-12-27
Schmidt Donal Ray Jr G-Gift 2,000,000 $0.26 2021-12-27
Punzi Henry Anthony 0 — 2021-08-27
Punzi Henry Anthony 0 — 2021-08-27
Justin Scott Suggs 0 — 2021-08-03

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms